The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?

Expert Opinion on Drug Safety
T Jock Murray

Abstract

Mitoxantrone, an immunosuppressant agent with potent anti-inflammatory activity, has been used to treat patients with multiple sclerosis (MS) who have worsening relapsing-remitting (RRMS) or secondary progressive multiple sclerosis (SPMS) despite prior therapy with interferons or glatiramer acetate. From previous experience of treating cancer with mitoxantrone, it was expected that cardiotoxic effects and occasional malignancy would develop in some patients treated with this agent. From the earliest trials, reduction of left ventricular ejection fraction (LVEF) was seen in 2-3% of cases, and in some this effect may persist and less commonly there can be congestive heart failure and even death. There are also occasional reports of leukaemia developing in MS patients treated with this agent. Mitoxantrone has been shown to reduce relapses, the number of new lesions visualised on magnetic resonance imaging and stop or reduce the progression of the disease in many patients treated. The drug has found a place in MS therapy because in this progressing group of MS patients who are failing on the disease-modifying therapies with interferons or glatiramer acetate, trials have shown that mitoxantrone may arrest or even improve many patien...Continue Reading

References

Feb 1, 1990·Neurology·Y SternJ W Langston
Jan 1, 1985·Investigational New Drugs·L E PosnerK Cartwright
Aug 1, 1994·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·S BastianelloC Andreula
Jan 24, 2002·Neurology·D S GoodinUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Pra
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael J RathboneKim L Pickering
Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Feb 1, 2003·Journal of the Neurological Sciences·R E Gonsette
Mar 6, 2003·Multiple Sclerosis : Clinical and Laboratory Research·Jagannadha R AvasaralaElliot E Abbey
Nov 26, 2003·Neurology·D S GoodinUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Dec 16, 2003·Brain, Behavior and Evolution·Kenneth C Catania, Fiona E Remple
Apr 20, 2004·CNS Drugs·Lesley J Scott, David P Figgitt
Aug 26, 2004·Multiple Sclerosis : Clinical and Laboratory Research·Raymond VoltzHans-Jochem Kolb
Dec 30, 2004·Neurology·Bruce A Cohen, Daniel D Mikol
Mar 30, 2005·Multiple Sclerosis : Clinical and Laboratory Research·N TéllezX Montalban
Apr 15, 2005·IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society·K Z Mao
May 11, 2005·Neurology·N C FoxUNKNOWN AN1792(QS-21)-201 Study
Jun 17, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Douglas R JefferyJonathon Burdette
Aug 13, 2005·Pharmacology & Therapeutics·Oliver NeuhausHans-Peter Hartung
Sep 15, 2005·Neurology·H KrapfUNKNOWN MIMS Study Group

❮ Previous
Next ❯

Citations

Mar 19, 2013·Journal of Neurology·Saeed BohlegaPeter Rieckmann
Jan 1, 2014·Clinical Neurology and Neurosurgery·Ivan Adamec, Mario Habek
Jul 5, 2008·International Journal of Pharmaceutics·ChunLei LiYongLi Wang
Jun 28, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·ChunLei LiYongLi Wang
Apr 5, 2012·The Journal of Pharmacy and Pharmacology·Mirela Enache, Elena Volanschi
Jul 22, 2014·Internal Medicine Journal·M T NolanT H Marwick
Nov 1, 2008·International Journal of Pharmaceutics·JingXia CuiMin Liang
Sep 17, 2013·Regulatory Toxicology and Pharmacology : RTP·Josef Finsterer, Peter Ohnsorge
Dec 3, 2014·Journal of the Neurological Sciences·Prudence TetteyIngrid A F van der Mei
Jun 29, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mirela EnacheMadalin I Enache
Feb 1, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Elham JadidiTahereh Moradi
Feb 19, 2014·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Vahe KehyayanJohn P Hirdes
Mar 17, 2007·The American Journal of Bioethics : AJOB·Ezekiel J Emanuel, Franklin G Miller
Jul 29, 2009·The Journal of Nursing Education·Barbara Battin Little
Jan 15, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O A TraktirskayaA N Boyko
Jan 11, 2020·International Journal of Preventive Medicine·Jamshid NajafianFardin Salehzadeh
Oct 5, 2016·Journal of Neurology·Anja ThormannPer Soelberg Sørensen
Jul 22, 2021·Multiple Sclerosis and Related Disorders·Matthew McAdamsTanuja Chitnis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
B C PestalozziC Sauter
Journal of Controlled Release : Official Journal of the Controlled Release Society
Jingxia CuiYongli Wang
© 2021 Meta ULC. All rights reserved